KURA Kura Oncology, Inc. gains 19% Feb 5, 2018
Developing in-licensed protein inhibitors for solid tumors and blood cancers. http://www.priceseries.com/trade/KURA-Kura-Oncology-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018011120180205.html